Effect of muscle relaxant on distribution of ventilation and aeration in patients with acute respiratory failure.

Effect of muscle relaxant on distribution of ventilation and aeration in patients with acute respiratory failure. - EIT monitoring before and after administration of muscle relaxant

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040207

Enrollment

Registered

2020-04-21

Start date

2020-04-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratory failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)mechanically ventilated patients with strong spontaneous breath 2)age 20<=, <=85 3)admission on ICU 4)written informed consent

Exclusion criteria

Exclusion criteria: 1)no allergy for muscle relaxant 2)patients with accelerated respiratory drive due to central nerve impairment 3)haemodynamic instability with mean arterial pressure less than 55 mmHg 4) insuitable for EIT belt placement 5)heart beat supported by pacemaker

Design outcomes

Primary

Measure	Time frame
change in end-expiratory lung impedance before and after administration of muscle relaxant	—

Countries

Japan

Contacts

Public ContactAtsuko Shono

Showa university Intensive care medicine

atsukos@med.showa-u.ac.jp03-3784-8575

Outcome results